Monaco's proton MC beam model and dose calculation algorithm were commissioned and validated on IBA Proteus ONE for clinical use. The first patient (November, 2024) was successfully treated, with daily dose delivery accuracy monitored via an in-house sCT platform.
Xu et al. (Wed,) studied this question.